XpandOrtho, Inc. Receives FDA 510(k) Clearance for Its Electronic Soft Tissue Balancing Instrument for Total Knee Replacement Surgery

My Subscriptions

Payment Confirmation

Transaction Failed

Your transaction failed, please try again or contact site support.

Clifford Colwell, M.D., President and Chairman of the Board, XpandOrtho, Inc. reports, XpandOrtho has initiated a clinical study at Scripps Clinic, La Jolla, CA and will be conducting a limited release of their product to selected surgeons in the US. “We are excited to give large and small volume surgeons the ability to reproducibly and accurately balance the ligaments of the knee over a full range of motion during total knee replacement.”

 

XpandOrtho, Inc., a designer of soft tissue balancing instruments, received FDA clearance on April 25th of 2017 for their electronic soft tissue balancing instrument for total knee replacement surgery.

The US Food and Drug Administration (FDA) awarded XpandOrtho 510(k) clearance for its sterile-packaged wireless disposable device that utilizes multiple miniaturized sensors and actuators to perform multiplanar balancing of the knee joint during a full range of motion. The device uses a novel constant pressure bellows system which wirelessly communicates with a display to provide dynamic multiaxial balance and selection of optimal thickness of the tibial component. The device can be conveniently used by all surgeons regardless of whether they choose to make the femoral cut first or the tibial cut first. Soft tissues can be released with the device in place enabling real time visual feedback to the surgeon. The “universal” design is compatible with almost all total knee implant systems from major manufacturers. This low-cost disposable device can also preserve an electronic record of the entire 3D balance of the knee at the end of the surgical procedure.

Clifford Colwell, M.D., President and Chairman of the Board, XpandOrtho, Inc. reports, XpandOrtho has initiated a clinical study at Scripps Clinic, La Jolla, CA and will be conducting a limited release of their product to selected surgeons in the US. “We are excited to give large and small volume surgeons the ability to reproducibly and accurately balance the ligaments of the knee over a full range of motion during total knee replacement.”

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.